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Abstract: Short Interspersed Nuclear Elements (SINEs) are non-autonomous
retrotransposons that comprise a large fraction of the human genome. SINEs are
demethylated in human disease, but whether SINEs become transcriptionally induced and
how the resulting transcripts may affect the expression of protein coding genes is unknown.
Here, we show that downregulation of the mRNA of the tumor suppressor gene BRCA1 is
associated with increased transcription of SINEs and production of sense and antisense
SINE small RNAs. We find that BRCA1 mRNA is post-transcriptionally down-regulated in
a Dicer and Drosha dependent manner and that expression of a SINE inverted repeat with
sequence identity to a BRCA1 intron is sufficient for downregulation of BRCA1 mRNA.
These observations suggest that transcriptional activation of SINEs could contribute to a
novel mechanism of RNA mediated post-transcriptional silencing of human genes.
Keywords: SINE; retrotransposon; BRCA1; post-transcriptional; gene regulation
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1. Introduction
Transposable elements have been shown to affect gene regulation in plants and fungi [1] and in
some animal species [2]. How transposable elements may regulate specific genes in humans is not well
understood, despite the fact that transposable elements constitute approximately half of the human
genome [3]. Retrotransposons that replicate by an RNA intermediate are of particular interest since
their RNAs can be directly targeted by a variety of post-transcriptional silencing mechanisms
(reviewed in [4]). Retrotransposons known to be currently active in the human genome are long
interspersed nuclear elements (LINEs), autonomous elements encoding their own enzymes needed for
reverse transcription and genomic integration, and short interspersed nuclear elements (SINEs),
non-autonomous elements that rely on the enzymes encoded within LINE sequences [5]. Recent
experiments have implicated retrotransposons in establishing DNA methylation patterns in cell
differentiation, in mammalian brain development, and in cancer [6±11]. In mouse, the Agouti viable
yellow allele of the agouti gene contains a mouse specific retrotransposon that induces differential
DNA methylation of retrotransposon DNA and results in differential expression of the agouti gene that
determines coat color [12]. In human bladder cancers, overexpression of a transcript variant of the
MET gene is driven by a LINE-1 promoter as the LINE-1 sequence becomes hypomethylated in cancer
progression [13]. A current, complete review of the role transposable elements may play in cancers has
recently been published [11]. Other mechanisms of retrotransposon cis-effects include the findings that
Alu elements, primate specific SINEs, can play roles in alternative splicing, RNA editing, translational
initiation, and transcription initiation and elongation [14±16].
Many human genes contain the highly repetitive SINE sequences within their introns and
untranslated regions, which results in transcripts containing SINE sequences. For example, the BRCA1
ORFXVFRQWDLQVRYHU6,1(VHPEHGGHGZLWKLQLWVLQWURQVDQGRQH6,1(ZLWKLQLWV¶875%HFDXVH
it is comprised of repetitive sequences whose transcription is driven by small divergent promoters, the
BRCA1 genomic structure (Figure 1A) has the potential to generate transcripts from both strands. For
example, transcription of NBR2 across the BRCA1 pseudogene sequence (denoted as <) would result
in a transcript with homology to the functional BRCA1 gene in the antisense orientation, thus raising
the potential for double-stranded RNA and subsequent siRNA formation with homology to BRCA1.
Additionally, BRCA1 and has a high density of SINEs (Figure 1C), raising the possibility that BRCA1
could be subject to transposable element mediated gene regulation within human cells. Given the
abundance and sequence similarity among different SINEs, production of small RNAs from SINE
elements located anywhere in the genome could target a variety of protein coding transcripts that have
regions of SINE sequence homology. Whether BRCA1 may be post-transcriptionally silenced is of
particular interest because BRCA1 is frequently downregulated in sporadic breast cancers without
associated mutations in the coding or promoter regions [17,18]. Additionally, promoter
hypermethylation occurs in only a small subset of the majority of sporadic breast cancers that exhibit
BRCA1 downregulation [19]. Thus, additional mechanisms of BRCA1 downregulation remain to be
discovered. Here, we explored the hypothesis that SINE sequences with homology to those found
within the BRCA1 locus function to post-transcriptionally downregulate BRCA1 mRNA in human
cultured cells. We found that BRCA1 downregulation in multiple breast cancer cell lines was not
associated with promoter methylation or a reduced transcription rate, but instead correlated with
increased bidirectional SINE transcription and the presence of SINE and BRCA1 small RNAs in cells

Genes 2013, 4

228

where BRCA1 was downregulated. Moreover, BRCA1 mRNA downregulation could be rescued by
depleting Dicer and Drosha, and in non-cancer cells partial reduction in BRCA1 transcript levels could
be achieved with ectopic transcription of double stranded SINE RNA with sequence identity to the
BRCA1 transcript. From these results, we suggest a model in which high levels of SINE RNAs
contribute to post-transcriptionally downregulate BRCA1 in human cells.
Figure 1. Human BRCA1 genomic structure. (A) The human BRCA1 genomic region
contains four genes and various types of repetitive sequences. The various regions
presented are not to scale. A large intrachromosomal segmental duplication (shown in b)
resulted in a partial pseudogene with homology to BRCA1 (denoted as \) and a partial
copy of NBR1 (NBR2). Two small (<250 bp) promoters drive divergent transcription of the
four genes. Hatched region: intergenic sequence. Arrows: direction of transcription from
divergent promoters. Location of probes used in nuclear run-on and small RNA blot
analyses are indicated, as are region 1 and 2 used in qRT-PCR experiments. (B) Location
of two intrachromosomal segmental duplications, with lengths of 14 kb and 24 kb, in
relation to BRCA1 and how run-on probes in Figure 2 fall within them. The 14 kb
duplication is represented by the red block and the 24 kb duplication is represented by the
blue block. (C) Image from the UCSC genome browser of the BRCA1 genomic locus. The
location of SINEs and other repetitive sequences within BRCA1 are indicated.
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2. Experimental Section
2.1. Cell Culture
WI-38 VA-13 cells were provided by the lab of Kathleen Dixon and were originally established
from fetal lung fibroblast [20]. HMEC were obtained from the University of Arizona Cancer Center
stock collection and were established from reduction mammoplasty [21]. MCF10A were obtained from
the University of Arizona Cancer Center stock collection and were established from fibrocystic disease
tissue [22]. MDA-MB-231, MCF7, UACC2087, UACC893, and ZR-75-1 were obtained from the stock
collection at the University of Arizona Cancer Center. MDA-MB-231, MCF7, and UACC2087 were
established from pleural effusions [23±25] and UACC893 and ZR-75-1 were established from primary
ductal carcinoma [26,27]. All lines were cultivated in the ATCC recommended media supplemented
with 1 U/milliliter penicillin, 1 U/milliliter streptomycin, and 0.5 nanogram/liter amphotericin.
2.2. RNA Extraction, Reverse Transcription, and qRT-PCR
RNA was extracted using RNeasy Kit (Qiagen), treated with DNAse (Ambion), and subsequently
purified using the RNA Clean and Concentrator Kit (Zymo). 1 milligram of total RNA was reverse
transcribed using the i-Script cDNA synthesis kit (Bio-Rad). 1 milliliter of cDNA was used in a qPCR
reaction. Data was quantified using MyIQ Software (Bio-Rad). qPCR reactions were carried out with
an annealing temperature of 58 C using 300 nanomolar final primer concentration and an extension
time of 45 seconds.
2.3. Nuclear Run-on
RNA probes were synthesized by in vitro transcription of PCR fragments carrying T3 promoter tails
using T3 RNA Polymerase (Promega). Nuclei were extracted from approximately 75 million cells as
described previously [28], with the exception that nuclei were directly isolated from human cultured
human cells rather than ground tissue. Briefly, cells were trypsinized and pelleted, then washed once in
ice cold PBS. Cells were subsequently lysed in 10mM TrisCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2,
0.5% (V/V) NP-40. The run-on reactions were then carried out as described previously [29].
All signals were normalized to E-actin.
2.4. Small RNA Enrichment and End Label Small RNA Filter Blots
Small RNA was enriched from total RNA samples by filtration through YM-30 columns
(Millipore). 1-2 milligrams of small RNA samples were end labeled with 32P g-ATP in a reaction using
T4 Kinase (Invitrogen). Samples were hybridized to dot blot membranes as prepared for nuclear
run-on in Ultra Hyb oligo buffer (Ambion) at 50 °C overnight. Two 15 minute washes were carried out
in 0.1% SDS, 2× SSC at 50 °C. All signals were normalized to miR-16 [30].
2.5. Knockdowns
Lentiviral transduction particles were purchased from Sigma. MDA-MB-231 cells were infected
according to manufacturer instructions. Cells were grown in 1.5 milligram/milliliter puromycin
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containing media after infection to maintain knockdown. Knockdown was verified by qRT-PCR as
described above.
Dicer Catalog # NM_0306212-1322s1c1; PIWIL4 catalog # NM_152431 1-1403s1c1; Drosha
catalog #NM_0132352-4340s1c1
Sodium Bisulfite Conversion of DNA and Sequenom Analysis Genomic DNA was bisulfite
converted using the EZ DNA Methylation Gold Kit (Zymo Research). The BRCA1 promoter was
amplified from converted DNA in a PCR reaction multiple products. 100 nanograms of PCR product
was submitted for a sequenom analysis through the University of Arizona Genetics Core. Data was
analyzed using the EpiTyper software (Sequenom).
2.6. Plasmid Generation and Nucleofections
SINE plasmid inserts were generated using PCR primers with appended restriction enzyme
recognition site tails and cloned in p-Tracer SV-40 (Invitrogen) using standard cloning techniques.
Nucleofection was accomplished according to Amaxa guidelines for cell line WI-38. Statistics were
GRQHXVLQJVWXGHQW¶VW-test for unpaired samples.
2.7. Determination of Hybridization Stringency Conditions
Oligos were engineered with various degrees of identity (ranging from 65%±100%) to laminB2, a
unique sequence in the human genome, and made into double stranded in vitro transcription templates
using a Klenow extension reaction. Riboprobes were made using in vitro transcription and spotted onto
nuclear run-on membranes. The transcription signal from nuclear run-on RNA was quantified for each
of these probes.
3. Results and Discussion
3.1. Reduction in Steady State BRCA1 Transcript Levels is not Associated with Promoter
Hypermethylation
To establish a cell culture system to investigate potential mechanisms of BRCA1 regulation, we
searched for a set of established human cell lines exhibiting differences in BRCA1 steady state
transcript levels. We desired a control cell line that exhibited high levels of steady state BRCA1
transcript compared to experimental cell lines. We additionally required control and experimental cell
lines to exhibit comparable low levels of BRCA1 promoter methylation, thus allowing us to investigate
previously uncharacterized mechanisms of BRCA1 regulation. BRCA1 transcript levels were measured
by quantitative reverse transcription PCR (qRT-PCR) in six breast cancer cell lines (MDA-MB-231,
MCF7, UACC2087, UACC893, and UACC3199), two non-cancerous mammary epithelial cell lines
(HMEC and MCF10A) and one fetal lung fibroblast cell line (WI-38 VA-13). Compared to all other
cell lines, BRCA1 mRNA was two to ten-fold higher in the fibroblast cell line (Figure 2A), making the
fibroblast cells the most suitable control for our studies. The two regions of BRCA1 analyzed
(Figure 1A VKRZHGVLPLODUH[SUHVVLRQSURILOHVUHJLRQVSDQVH[RQWRWKH¶875DQGUHJLRQ
spans exons 10 and 11. DNA methylation levels at the BRCA1 promoter [31] were analyzed in all cell
lines. UACC3199, which had previously been shown to exhibit methylation at the BRCA1 promoter
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served as a positive control [32]. All the sporadic breast cancer cell lines showed very little
methylation within the BRCA1 promoter and did not differ significantly from the fibroblast cells
(Figure S1). These data suggest that the observed low BRCA1 transcript levels in the sporadic breast
cancer cells are not associated with promoter hypermethylation.
Figure 2. BRCA1 and genomic region expression in cell lines. (A) BRCA1 mRNA levels
analyzed by qRT-PCR. Average and standard error of two biological replicates for each
cell line are shown. (B) BRCA1 transcription in fibroblast cell line and sporadic breast
cancer cell lLQHV 3UREHV    DQG ¶ 875 DUH IURP BRCA1 exons and assay
transcription solely from the BRCA1 gene; pseudo probe assays transcription from exon
one of both the BRCA1 gene and the pseudogene. S detects transcription in the sense
orientation, and AS detects transcription in the antisense orientation, relative to BRCA1
transcription. (C) Transcription of other sequences within the BRCA1 genomic region.
NBR2: NBR2 exon; Prom. A, bidirectional promoter shared between BRCA1 and NBR2;
Prom. B, alternative BRCA1 promoter within first exon; DB546216 and AA622657, two
ESTs transcribed from same sequence but in opposite orientations. The NBR2, Prom. B,
DB546216 and AA622657 probes all contain SINEs. (D) Transcription of SINEs within
BRCA1 introns. Each probe spans 3±4 individual SINEs. Sense (S) and antisense (AS)
refer to the SINE transcription orientation relative to the BRCA1 coding transcript. See
panel A for location of all probes in (B) through (D). Nuclear run-on data depicted in (B)
through (D) represents one experiment with each cell line, although similar results were
observed in other experiments using a subset of probes depicted here.
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While it would have been ideal to have a tissue specific control cell line, HMEC and MCF10A were
not appropriate controls because of their low steady state BRCA1 transcript levels. Previous reports
indicated that BRCA1 expression was higher in the HMEC line relative to sporadic breast cancer cells
and that the promoter was relatively unmethylated [32], but this was not replicated, presumably
because the BRCA1 promoter became methylated during passage of the HMEC cell line. In addition,
the extensive BRCA1 promoter DNA methylation in HMEC (Figure S1) eliminated HMEC as a
control, given that promoter methylation was likely to be regulating transcription of BRCA1. We found
that, although BRCA1 mRNA levels in MCF10A are comparable to the cancer cell lines (Figure 2), it
is transcribed at a reduced rate in MCF10A cells compared to the fibroblast and cancer cell lines
(Figure S2). These results imply that the BRCA1 transcript is more stable in the MCF10A cells than in
the breast cancer lines, raising the possibility that regulation of the BRCA1 transcript occurs by
different mechanisms in the MCF10A cells than in the breast cancer cell lines. Thus, MCF10A was
also eliminated as a potential control cell line, as clear differences exist in regulation of BRCA1
between these cells and the cancer cell lines.
3.2. Downregulation of BRCA1 Transcript Levels is not Associated with a Reduced Transcription Rate
We wished to determine whether the differences in steady state BRCA1 transcript levels between
the fibroblast cells and the sporadic breast cancer cell lines was due to differences in transcription. We
performed nuclear run-on analysis to investigate transcription of BRCA1 specific sequences in the
fibroblast cell line and sporadic breast cancer cell lines. We observed no obvious difference in the
transcription rate of BRCA1 between the breast cancer cell lines and the fibroblast control cell line
(Figure 2B), despite 2 to 10-fold differences (P 6WXGHQW¶VW-test assuming unequal variance) in
BRCA1 steady state mRNA levels. These data suggest that differences in transcription are not
contributing to the lower levels of BRCA1 mRNA levels in the cancer cell lines relative to the
fibroblast cell line. Thus, we hypothesized that BRCA1 is likely to be downregulated at the posttranscriptional level in the sporadic breast cancer cells. Because the fibroblast cell line exhibited higher
levels of BRCA1 steady state mRNA compared to the sporadic breast cancer cell lines, yet had similar
transcription rates and similar levels of promoter methylation, it was used as a control in all subsequent
experiments to investigate post-transcriptional regulatory mechanisms resulting in the low levels of
BRCA1 mRNA in the cancer cell lines.
3.3. Repeat Sequences Are Highly Transcribed in Sporadic Breast Cancer Cell Lines
Although nuclear run-on experiments demonstrated that the rate of transcription of BRCA1 exons
was no different in control and cancer cell lines (Figure 2B), it remained possible that transcription of
UHSHDWVHTXHQFHVZLWKVHTXHQFHVLPLODULW\WRWKHLQWURQVRU¶875RIBRCA1 could be upregulated. To
investigate this idea, nuclear run-on transcription was analyzed using repetitive regions within and
surrounding BRCA1 as probes, including the introns that contain multiple SINEs. We observed that
transcription from SINE sequences with high sequence similarity to those found within the BRCA1
locus was increased in the sporadic breast cancer cell lines in both the sense (S) and antisense (AS)
orientations compared to the fibroblast cell line (Figures 2C,D). We did observe a range of SINE
transcriptional upregulation, with some breast cancer cell lines exhibiting comparable levels to the
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fibroblast and others showing dramatically higher levels. We do not find this surprising, however, as
each cancer cell line was obtained from a different diseased individual and is therefore biologically
distinct. However, we do observe the general trend that SINE transcription is increased in the breast
cancer cell lines compared to the fibroblast cells.
A pair of intrachromosomal segmental duplications also occur within the BRCA1 region: a 14-kb
and a 24-kb duplication. After the original segmental duplication, other insertions occurred within the
24-kb duplication, thus explaining its larger size. The location of these duplications and how other
nuclear run-on probes fall within them is depicted in Figure 1B and Figure S3A. We observed that
transcription across the 14-kb intrachromosomal segmental duplication was elevated 2 to 30-fold
(Figure S3B; location of probes relative to BRCA1 shown in Figure 1B and Figure S3A); and
transcription of SINEs with sequence similarity to those within BRCA1 introns was upregulated 2 to
15-fold (Figure 2D). Other probes containing SINE sequences (Promoter B, NBR2, and
DB546216/AA622657) were upregulated 2 to 8 fold (Figure 2C). We conclude that multiple repetitive
regions, including SINEs, are transcribed at high levels in sporadic breast cancer cells relative to the
control fibroblast cells. A similar trend was observed in other nuclear run-on experiments: high
transcriptional signal was observed from SINEs in the breast cancer cell lines, while comparatively
low transcriptional signal was observed from the same probes in control cells. The data we present is
from one representative experiment. Interestingly, we observe similar levels of transcription in both the
sense and antisense orientation from all probes analyzed, including BRCA1. However, this is not
surprising, given that transcript profiling has revealed the presence of high amounts of both sense and
antisense transcripts from protein coding genes in many organisms, including humans [33].
Because many of the repeats within BRCA1 introns are SINEs and these SINEs have significant
sequence similarity to large numbers of SINEs throughout the genome, we tested the stringency of our
hybridization conditions and determined that they allowed for detection of transcripts with
approximately 85% sequence identity or higher to our probes (Figure S4). A bioinformatic query of the
entire human genome indicated that each SINE probe we used, which had 100% sequence identity to
the BRCA1 SINEs, could also detect transcripts from a substantial number of additional sequences
throughout the genome. Non-BRCA1 associated SINE sequences ranged from approximately 150 to
180,000 different SINEs, assuming a minimum length of 250 bp and a minimum of 85% sequence
identity (Table S1). Thus, it was not possible to identify the specific location(s) from which SINE
transcription was occurring. Given the substantial transcription levels observed, it is likely multiple
locations are being transcribed.
3.4. Small RNA Species from BRCA1 and Associated Retrotransposons Are Elevated in Breast Cancer
Cell Lines
The observation that both sense and antisense transcription was detected from SINEs with high
sequence similarity to those found within the BRCA1 locus (Figure 2D) suggested that double-stranded
RNA to SINE sequences might be present and potentially processed into small RNAs. To investigate
this hypothesis, the abundance of small RNAs complementary to probes derived from SINE sequences
within the BRCA1 genomic region were compared between the breast cancer cell lines and the
fibroblast cell line. We enriched for RNAs 60 nucleotides or smaller, end-labeled this small RNA

Genes 2013, 4

235

enriched population with 32P g-ATP and used it to probe membranes containing the same target
sequences used for the nuclear run-on analyses (see Figure 1A for probe locations). Small RNA
species from both the sense (S) and antisense (AS) strand from multiple regions within the BRCA1
genomic locus (Figure 3A,C), SINEs with high sequence identity to those in the BRCA1 introns, and
repetitive sequences within the 14 kb segmental duplication (Figure S3C), were elevated in the
sporadic breast cancer cell lines. The observation that BRCA1 exon-specific (non-repeat) small RNAs
were also increased 2 to 6-fold in several of the breast cancer cell lines relative to the fibroblast cell
line (Figure 3A) was consistent with a post-transcriptional RNA degradation mechanism contributing
to the lower mRNA levels observed in the breast cancer cell lines.
To eliminate the possibility that the small RNA blots simply assayed degradation fragments of
intact transcripts, levels of small RNA from the GAPDH and ubiquitin messages, which contain no
SINEs within their sequences, were analyzed within the same samples used to measure BRCA1 and
SINE small RNAs and compared between cell lines. With the exception of MDA-MB-231, small RNA
levels of these transcripts did not vary greatly between the cell lines (Figure S5). In all cases, the small
RNAs from both BRCA1 exonic sequences and the SINE sequences were higher in the cancer cell lines
relative to the fibroblast than the small RNAs from GAPDH and ubiquitin genes.
3.5. BRCA1 Downregulation Occurs Through Dicer and Drosha
The correlation of low BRCA1 mRNA levels with increased small RNA species from both BRCA1specific sequences and the repetitive SINE sequences located within BRCA1 and elsewhere in the
genome, suggested RNA processing pathways may be involved in downregulation of BRCA1. To test
whether known post-transcriptional RNA regulation pathways might play a role in downregulating
BRCA1 transcript levels, the cancer cell line MDA-MB-231 was treated with lentiviral particles
containing short hairpin RNA (shRNA) constructs targeting specific RNA processing enzymes. The
cells were individually treated with lentiviral constructs targeting PIWIL4, Drosha, and Dicer to test
for possible roles of the PIWI interacting RNA (piRNA), microRNA (miRNA), and small inhibitory
RNA (siRNA) pathways in BRCA1 regulation. Controls included non-infected cells and cells infected
with a lentiviral shRNA construct against GFP, which does not target any sequence in the human
genome. The same two regions of BRCA1 were analyzed as described above (Figure 2A). Successful
knockdown of all three RNA processing genes was achieved (Figure 4). Because expression levels of
PIWIL4, Dicer, and Drosha (Figure 4) and four other RNA processing enzymes (Figure S6) were
affected in GFP shRNA infected cells compared to non-infected cells, expression levels of the
enzymes targeted by shRNA and those of BRCA1 in the knockdown cells were normalized to GFP
shRNA infected control cells.
While there was no significant effect on BRCA1 transcript levels in PIWIL4 knockdown cells
(Figure 4A), in Dicer knockdown cells BRCA1 transcript levels were significantly increased by an
average of 6-fold (standard error 1.5, P 6WXGHQW¶VW-test assuming unequal variance) across four
biological replicates (Figure 4B). Similarly, in Drosha knockdown cells BRCA1 mRNA levels were
increased by an average of 4-fold (standard error 1, P   6WXGHQW¶V W-test assuming unequal
variance) across six biological replicates (Figure 4C). The two analyzed regions of BRCA1 consistently
behaved differently in degree of rescue; therefore, both are shown individually (Figure 4). Together,
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these results suggest that both Dicer and Drosha contribute to downregulation of BRCA1 transcripts in
the sporadic breast cancer cell lines.
Figure 3. BRCA1 region and SINE small RNAs in control and cancer cell lines.
Probe nomenclature described in legend of Figure 1 and location of probes are indicated in
Figure 1A. (A) BRCA1 pseudogene and exons; (B) sequences surrounding and within
BRCA1; and (C) SINEs within BRCA1 LQWURQV 9DOXH IRU ¶ 875 $6 IURP ILEUREODVW LV
negative and 1 for MCF7. Data presented represents one experiment with each cell line.

Genes 2013, 4
Figure 4. BRCA1 downregulation requires Dicer and Drosha but not PIWIL4. (A) PIWIL4
and BRCA1 expression in PIWIL4 knockdown MDA-MB-231 cells, non-infected cells, and
GFP shRNA infected cells. Data shown is average and standard error of BRCA1 and
PIWIL4 expression in two independent infections with PIWIL4 shRNA lentivirus. P-value
comparing PIWIL4 expression in GFP shRNA infected cells and PIWIL4 knockdown cells
is 0.04. (B) Dicer and BRCA1 expression in Dicer knockdown MDA-MB-231 cells,
non-infected cells, and GFP shRNA infected controls. Data shown is average and standard
error of BRCA1 and Dicer expression in four independent infections with Dicer shRNA
lentivirus. P-values comparing expression levels of BRCA1 between GFP shRNA treated
cells and Dicer shRNA treated cells: value for region 1 is 0.03, value for region 2 is 0.015.
P-value comparing Dicer expression in GFP shRNA infected cells and Dicer knockdown
cells is 0.002. (C) Drosha and BRCA1 expression in Drosha knockdown MDA-MB-231
cells, non-infected cells, and GFP shRNA infected controls. Data shown is average and
standard error of BRCA1 and Drosha expression in six independent infections with Drosha
shRNA lentivirus. P-values comparing expression levels of BRCA1 between GFP shRNA
treated cells and Dicer shRNA treated cells: value for region 1 is 0.014, value for region 2
is 0.005. P-value comparing Drosha expression in GFP shRNA infected cells and Drosha
knockdown cells is 2.5 × 10í. In each experiment, expression of the target gene within
each cell line was normalized to actin and the GFP shRNA cells were set to 1.
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3.6. Ectopic Expression of SINE Sequences Induces Downregulation of BRCA1 in Non-Cancer Cells
To determine whether increased dsRNA from SINE sequences could downregulate BRCA1 mRNA
levels in non-cancer cells, transient transfection assays were used in the fibroblast cells to express an
inverted repeat of the SINE 1 probe sequence, which is 100% identical to a SINE within BRCA1
(Figure 5A). Transfection efficiency, as observed by GFP expression, was close to 100% (Figure 5B).
Cells transfected with the SINE inverted repeat construct showed 2-fold, (standard error 0.1, P = 0.004,
6WXGHQW¶VW-test assuming unequal variance) lower BRCA1 mRNA levels, measured by qRT-PCR, as
compared to the mock treatment (Figure 5C). We repeat this experiment in two other human cell types,
HeLa and HEK293-T cells; however, we observed no reduction of BRCA1 mRNA levels upon SINE
inverted repeat transfection (data not shown). These results may indicate that SINE mediated
knockdown of BRCA1 is a tissue specific phenomenon of gene regulation. Transfection of fibroblast
cells with plasmids expressing sense or antisense SINE sequence, relative to the BRCA1 transcript,
resulted in no significant alterations in BRCA1 mRNA levels (Figure S7). This is not surprising as a
review of the literature indicates that hairpin RNA is a much more efficient silencer than sense or
anti-sense RNA [34,35]. Of the ~150 additional human genes identified to contain SINEs with high
sequence identity to the SINE 1 probe within their introns, four were tested for downregulation upon
transfection with the SINE 1 inverted repeat, but none of these genes were downregulated six hours
post transfection (Figure S8). This result could be because the similarity was not 100% to the SINE 1
sequence (Figsures S9-S12), reducing the number of small RNAs with perfect complementarity to
each target gene. In contrast, each small RNA generated from the SINE 1 inverted repeat would
perfectly match the BRCA1 transcript. Thus, it may be that a certain threshold in the number of SINE
small RNAs that retain a perfect or near perfect match to a target gene may be required to effectively
trigger transcript degradation.
Examination of transcription rates of BRCA1 revealed that although breast cancer lines had lower
steady state levels of BRCA1 mRNA, they did not differ in BRCA1 transcription rate when compared
to each other and to fetal lung fibroblast, which had a much higher level of BRCA1 transcripts. This
suggests a post-transcriptional mechanism is operating to downregulate BRCA1 in the breast cancer
cell lines. We cannot exclude the possibility that this post-transcriptional mechanism is due to
differences in the tissue type of our control fibroblast cells when compared to breast cells rather than
the transformed nature of the cancer cell lines. However, SINE mediated transcript regulation in
human cells is an exciting and novel observation, regardless of whether it occurs in healthy vs.
diseased states or in a tissue specific context. Our observations nevertheless suggest a novel RNAmediated post-transcriptional silencing mechanism in which SINE upregulation (likely throughout the
genome) is contributing to post-transcriptional targeting of BRCA1 RNA. Given the correlation with
increased transcription of both the sense and antisense orientation from SINEs, a reduction in BRCA1
steady state transcripts and increased small RNAs homologous to SINE sequences and BRCA1-specific
sequences, we hypothesize the increased SINE transcripts and small RNAs are triggering BRCA1 RNA
degradation. Consistent with this hypothesis, the low BRCA1 mRNA levels could be rescued by
depleting Dicer and Drosha functions. Our experiments cannot distinguish whether Dicer and Drosha
are acting directly on the BRCA1 RNA or whether the miRNA and siRNA pathways or solely the
miRNA pathway is required. However, the observation that SINE inverted repeat expression can
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induce BRCA1 downregulation is most consistent with a siRNA mechanism, as the small RNAs
generated from the inverted repeat would target intronic BRCA1 sequences.
Figure 5. Ectopic expression of SINE sequences induces downregulation of BRCA1.
(A) Diagram of plasmid and experimental strategy. An inverted repeat to the SINE 1 probe
used in the run-on and small RNA blots, which is 100% identical to the SINE located
within BRCA1 intron 3, was cloned under the control of the highly expressing SV40
promoter. Within the same plasmid, GFP is under the control of the highly expressing
CMV promoter. (B) Transfection efficiency as shown by number of cells in bright field
(left) exhibiting GFP expression (right). Upper image shown is cells treated with the empty
vector 6 hours post transfection; lower image is one biological replicate of SINE 1 inverted
repeat 6 hours post transfection. (C) BRCA1 transcript levels 6 hours post-transfection, as
determined by qRT-PCR. Data shown is average and standard error of four biological
replicates. P-value for BRCA1 expression between the mock treatment and treatment with
the SINE 1 IR is 0.004.
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We propose a model whereby BRCA1 can be regulated post-transcriptionally by a pathway initiated
through increased bidirectional transcription of SINEs or production of sense and antisense SINE RNA
from different loci. This increased SINE transcription, which is likely to occur at hundreds or
thousands of sites throughout the genome, may generate dsRNA that subsequently could be processed
into SINE small RNAs. BRCA1 has a high density of SINEs within its introns, and SINE small RNAs
could target the BRCA1 transcript for degradation in trans. It is important to stress that the SINEs from
which transcription is highest may or may not be those within the BRCA1 locus: small RNAs
originating from SINEs at distant genomic regions could target the SINE dense BRCA1 transcript via
sequence identity. Our results demonstrating that expression of a SINE hairpin RNA is sufficient to
decrease in BRCA1 transcript levels is consistent with a trans-acting model.
Our findings suggest a novel mechanism might be governing the regulation of BRCA1 transcripts.
The observation that non-cancer fibroblast cells can be induced to specifically downregulate BRCA1
steady state mRNA levels by expressing a SINE inverted repeat suggests that SINE transcription and
subsequent generation of dsRNA and small RNAs could target protein coding transcripts in human
cells. Whether the postulated SINE RNA destruction of primary transcripts is limited only to disease
states where endogenous SINE transcription is upregulated, as in the breast cancer cell lines, is
currently unknown. In support of the hypothesis that retrotransposon derived small RNAs can target
SURWHLQFRGLQJJHQHVUHFHQWUHSRUWVVKRZWKDWSL51$VFDQWDUJHW¶875VRISURWHLQFRGLQJWUDQVFULSWV
in Drosophila and Xenopus [36]. Additionally, transcripts that contain Alu elements within their
¶875FDQEHWDUJHWHGE\ORQJQRQ-coding RNAs (lncRNAs) with complementary Alu sequences for
the STAU-1 RNA decay pathway [37]; notably, this model is similar to what we propose in that one
Alu containing lncRNA can target a variety of protein coding transcripts containing sequence
homology provided by Alu HOHPHQWVZLWKLQWKHLU¶875
4. Conclusions
Given the tremendous number and sequence divergence of different SINE families within the
human genome, we speculate that controlled transcription of specific SINE family members could
have evolved as a gene regulation mechanism for human genes that, like BRCA1, contain large
QXPEHUV RI LQWURQLF DQG ¶-UTR SINE sequences. Further, in diseases where SINE deregulation has
been known to occur, such as cancer, it may be an unexplored mechanism contributing to loss of gene
expression attributed to the disease phenotype.
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